Active Research

  • An Open-label, Multi-center, Phase IV, Rollover Study for Patients with Sickle Cell Disease who have Completed a prior Novartis-Sponsored Crizanlizumab Study

    Primary Investigator: Johnson MD, Clarissa

    IRB ID: 2021-060 (OPEN)

  • ASH Data Hub: A Multi-Center Data Hub of Individuals Living with Hematologic Disease

    Primary Investigator: Johnson MD, Clarissa

    IRB ID: 2022-116 (OPEN)

  • CHAT: A Multi-Institutional Children’s Healthcare Advancements in Thrombosis Registry

    Primary Investigator: Torres MD, Marcela

    IRB ID: 2022-077 (OPEN)

  • Cook Children’s Health Care System Stroke and Thrombosis Registry

    Primary Investigator: Torres MD, Marcela

    IRB ID: 2020-037 (OPEN)

  • Focal Cerebral Arteriopathy Steroid (FOCAS) Trial (Comparative Effectiveness Trial)

    Primary Investigator: Torres MD, Marcela

    IRB ID: 2023-029 (OPEN)

  • Functional Characterization of Children with Chronic Venous Thromboembolic Disease

    Primary Investigator: Torres MD, Marcela

    IRB ID: 2021-065 (OPEN)

  • International Paediatric Stroke Study-Towards the Establishment of Standards of Practice and the Initiation of Multi-Center, Multi-National Clinical Trials for Neonates and Children with Stroke (IPSS)

    Primary Investigator: Torres MD, Marcela

    IRB ID: 2012-008 (OPEN)

  • IPIG 5674-0001 Observational Registry Protocol: The International PNH Interest Group PNH Registry

    Primary Investigator: Beam MD, Donald

    IRB ID: 2022-093 (OPEN)

  • NN7415-4616: Open-label study investigating efficacy, safety and pharmacokinetics of concizumab prophylaxis in children below 12 years with haemophilia A or B with or without inhibitors

    Primary Investigator: McCavit MD, Timothy

    IRB ID: 2024-012 (OPEN)

  • Observational study of pediatric thrombotic disease: the Throm-PED registry

    Primary Investigator: Torres MD, Marcela

    IRB ID: 2021-085 (OPEN)

  • Project DANCES (Diversity in Aya caNCEr Survivors)

    Primary Investigator:

    IRB ID: 2024-048 (OPEN)

  • RBDD-PLG Project; International Retrospective and Prospective Study of Individuals affected with Hypoplasminogenemia

    Primary Investigator: Torres MD, Marcela

    IRB ID: 2019-028 (OPEN)

  • Seizures and Children's Outcomes After Stroke (SCOUTS)

    Primary Investigator: Herring, Rachelle

    IRB ID: 2022-067 (OPEN)

  • The American Thrombosis and Hemostasis Network (ATHN) National Web Tracker

    Primary Investigator: Sanders MD, Joann

    IRB ID: 2011-160 (OPEN)

  • X4P-001-110: A Phase 3, randomized, double-blind, placebo-controlled, multicenter study of mavorixafor in participants with congenital and acquired primary autoimmune and idiopathic chronic neutropenic disorders who are experiencing recurrent and/or serious infections.

    Primary Investigator: Beam MD, Donald

    IRB ID: 2024-091 (OPEN)